Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  News  >  Companies  >  All News

News : Companies

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors

U S Stem Cell : USRM Chief Scientist Talks Stem Cell Journey, Autologous Stem Cells with ‘Something Significant’ Happy Living Podcast

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/17/2018 | 04:44pm CEST

SUNRISE, FL - May 17, 2018- U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced its Chief Science Officer, Dr. Kristin Comella, is featured in the 'Something Significant' Happy Living podcastwith former NFL player Matt Gersper, where she discusses the inception of her work more than 19 years ago and how she and USRM's development of novel, therapeutic adipose (fat derived) stem cell treatments, is changing lives. The interview is available for complementary playback here.

Dr. Comella,a world renowned expert in the development and clinical application of autologous stem cellproducts and therapies, is one voice in a growing movementrecognizing the power of regenerative medicine and, in particular, autologous stem cell therapy. Last month, Dr. Comella and her team were the first in the world to publish in-human results in the scientific literatureabout adipose-derived, autologous stem cells for the treatment of psoriasis - a chronic, painful skin condition that affects more than 7 million Americans every year. She is frequently publishedin the scientific literature on the practical application of autologous stem cells for regenerative medicine.

Matt Gersperis the founder of Happy Living and author of The Belief Road Map& Turning Inspiration Into Action. He is a graduate of U.C. Davis and a former football player for the Canadian, USFL and NFL football leagues. During the past few years, he shifted his business to researching and sharing best practices for happy living with the world. His mission is to inspire others to live their best self.

As more and more Americansare beginning to discover the opportunity to use their own stem cells for healing, demand for information about her work has been increasing. Recently, she was featured in the Jeff Hays' documentary, 'The Healing Miracle(available for listen here) ;' a featured guestfor the Biohacker Centerin Helsinki, Finland (available in its entirety here), and a featured guest on Health Boot Camps' 'The Fountain of Health Has Been Found: An Interview with Dr. Kristin Comella,' (now available on podcast here).

U.S. Stem Cell, Inc.is a leader in the regenerative medicine / cellular therapy industry specializing in physician training and certification and stem cell products including its lead product AdipocellTM, as well as veterinary stem cell training and stem cell banking and creation and management of stem cell clinics. To management's knowledge, USRM has completed more clinical treatments than any other stem cell company in the world in the past 20 years.

Forward-Looking Statements: Except for historical matters contained herein, statements made in this press release are forward-looking statements. Without limiting the generality of the foregoing, words such as 'may', 'will', 'to', 'plan', 'expect', 'believe', 'anticipate', 'intend', 'could', 'would', 'estimate', or 'continue', or the negative other variations thereof or comparable terminology are intended to identify forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements and represent our management's beliefs and assumptions only as of the date hereof. Except as required by law, we assume no obligation to update these forward-looking statements, even if new information becomes available in the future. The Company's business and the risks and uncertainties of the business are described in its filings with the Securities and Exchange Commission which can be found at sec.gov.

Disclaimer

U.S. Stem Cell Inc. published this content on 17 May 2018 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 17 May 2018 14:43:06 UTC

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news "Companies"
01:06aWOLF MINERALS : Funding Update Satisfaction of Conditions Precedent
PU
01:05aSUPERDRY : founder donates GBP 1m to 2nd Brexit vote campaign
AQ
01:01aHEALINT : Announces Research Showing Increase in Anxiety and Depression with Higher Migraine Frequency Among Tens of Thousands of US Migraine Patients
BU
01:01aCIENA : Strengthens Presence in Japan with New Office
BU
12:56aLIONTOWN RESOURCES : expands lithium footprint in WA
PU
12:51aMCGRATH : Final share buy-back notice - Appendix 3F Opens in a new Window
PU
12:46aATLAS IRON : Further extension of Hancock Offer
PU
12:41aBATHURST RESOURCES LIMITED : Request for Trading Ha
PU
12:36aTAP OIL : Change in Substantial Shareholding
PU
12:34aVOLKSWAGEN : Mexico agrees 5.5 percent salary hike for workers - union
RE
Latest news "Companies"
Advertisement